Rare diseases
Investigational molecules
Locations
A study to evaluate the effect of CX11 trometamol monohydrate in patients with type 2 diabetes
PolandEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
PolandA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
PolandA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
PolandEfficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
PolandEvaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
PolandA Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome
PolandA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
PolandA study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese
PolandA Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies
PolandA Study Testing Imeroprubart for Adults with Primary Sjogren's Disease with Moderate to Severe Symptoms
PolandA study to test if tibulizumab works and is safe for adults with systemic sclerosis
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
